Journal of Cancer Research and Clinical Oncology

, Volume 124, Issue 12, pp 677–682 | Cite as

Expression of sucrase and intestinal-type alkaline phosphatase in colorectal carcinoms in rats treated with methylazoxymethanol acetate

  • Kimihide Yoshida
  • Wataru Nakamura
  • Kazuyuki Hirano
  • Hirofumi Yuasa
  • Tetsuya Tsukamoto
  • Masae Tatematsu
ORIGINAL PAPER

Abstract

In this study the small-intestine phenotype in rat colonic tumors was investigated in terms of sucrase and intestinal-type alkaline phosphatase (I-ALP) activity. F344 rats were given intraperitoneal injections of methylazoxymethanol acetate at a dose level of 25 mg/kg body weight once a week for 8 weeks and were killed 40 weeks after the first injection. Sucrase and I-ALP activities in proximal and distal colon adenocarcinomas were significantly higher than those in the normal colon epithelium. In the jejunum, by contrast, normal tissue had significantly higher levels than tumors. Immunohistochemical staining of I-ALP was also strong in striated cell borders of colon adenocarcinoma cells. These data suggest that, whereas absorptive cells of the small intestine lose their own traits with tumor development, colonocytes acquire phenotypic features of the small intestine. Intestinal enzymes associated with the striated-cell border, such as sucrase and I-ALP, may be useful markers for malignant phenotypic expression in colonocytes.

Key words Small-intestine phenotype Sucrase Intestinal-type alkaline phosphatase Colon cancer Rat 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Kimihide Yoshida
    • 1
  • Wataru Nakamura
    • 1
  • Kazuyuki Hirano
    • 2
  • Hirofumi Yuasa
    • 1
  • Tetsuya Tsukamoto
    • 1
  • Masae Tatematsu
    • 1
  1. 1.Laboratory of Pathology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464–8681, Japan Tel.: +81-52-762-6111 Fax: +81-52-763-5233JP
  2. 2.Gifu Pharmaceutical University, 6-1 Mitahorahigashi 5, Gifu, 502-8585, JapanJP

Personalised recommendations